Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067480 · ClinicalTrials.gov registry record · NA
Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients
A NA study, sponsored by East Tennessee State University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03067480 is a NA study that was terminated before completion, run by East Tennessee State University. The registered enrollment target is 12 participants.
The verdict
NCT03067480, a NA study, was terminated before completion, sponsored by East Tennessee State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
To determine whether 3-month versus 6-month professional CGM utilization improves time spent in target range of 70-140mg/dl in patients with poorly controlled T2DM not treated with insulin.
Interventions
- DEVICE iPro2 Professional CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03067480
The ClinicalTrials.gov registry entry for NCT03067480 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Tennessee State University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iPro2 Professional CGM is the first listed.
NCT03067480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03067480 about?
NCT03067480 is a clinical study titled "Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients". To determine whether 3-month versus 6-month professional CGM utilization improves time spent in target range of 70-140mg/dl in patients with poorly controlled T2DM not treated with insulin.
What is the current status of trial NCT03067480?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2017-06-06. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03067480?
The interventions under investigation include: iPro2 Professional CGM (DEVICE).
Who is sponsoring clinical trial NCT03067480?
This trial is sponsored by East Tennessee State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.